Lisa D. Edwards
- Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohortBy Alvar Agusti, Lisa D. Edwards, Bartolomé Celli, William MacNee, Peter M. A. Calverley, Hana Müllerova, David A. Lomas, Emiel Wouters, Per Bakke, Steve Rennard, Courtney Crim, Bruce E. Miller, Harvey O. Coxson, Julie C. Yates, Ruth Tal-Singer and Jørgen VestboAlvar Agusti1Thorax Institute, Hospital Clinic, IDIBAPS, Universitat de Barcelona and CIBER Enfermedades Respiratorias, FISIB, Mallorca, SpainLisa D. Edwards2GlaxoSmithKline, Research Triangle Park, NCBartolomé Celli3Dept of Respiratory Medicine; Brigham and Women's Hospital, Boston, MAWilliam MacNee4University of Edinburgh & Royal Infirmary, EdinburghPeter M. A. Calverley5Dept of Respiratory Medicine, University Hospital Aintree, LiverpoolHana Müllerova6Epidemiology, GlaxoSmithKline R&D, MiddlesexDavid A. Lomas7Dept of Medicine, University of Cambridge, Cambridge Institute for Medical Research, CambridgeEmiel Wouters8Dept of Respiratory Medicine, Maastricht University Medical Centre, Maastricht, The NetherlandsPer Bakke9Institute of Medicine, University of Bergen, Bergen10Dept of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwaySteve Rennard11University of Nebraska Medical Center, Omaha, NECourtney Crim2GlaxoSmithKline, Research Triangle Park, NCBruce E. Miller12GlaxoSmithKline, King of Prussia, PA, USAHarvey O. Coxson13Dept of Radiology, University of British Columbia, Vancouver General Hospital, Vancouver, BC, CanadaJulie C. Yates2GlaxoSmithKline, Research Triangle Park, NCRuth Tal-Singer12GlaxoSmithKline, King of Prussia, PA, USAJørgen Vestbo14Dept of Respiratory Medicine, Odense University Hospital/University of Southern Denmark, Denmark15Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK
- Characteristics, stability and outcomes of the gold 2011 copd groups in the eclipse cohortBy Alvar Agusti, Lisa D. Edwards, Bartolomé Celli, William MacNee, Peter M. A. Calverley, Hana Mullerova, David A. Lomas, Emiel Wouters, Per Bakke, Steve Rennard, Courtney Crim, Bruce E. Miller, Harvey O. Coxson, Julie C. Yates, Ruth Tal-Singer, Jørgen Vestbo and for the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators (see Appendix)Article | Published in 2013 in European Respiratory JournalAlvar Agusti*Thorax Institute, Hospital Clinic, IDIBAPS, Universitat de Barcelona and CIBER Enfermedades Respiratorias, FISIB, Mallorca, SpainLisa D. Edwards#GlaxoSmithKline, Research Triangle Park, NC, USABartolomé Celli¶Dept of Respiratory Medicine; Brigham and Women's Hospital, Boston, MA, USAWilliam MacNee+University of Edinburgh & Royal Infirmary, Edinburgh, UKPeter M. A. Calverley§Dept of Respiratory Medicine; University Hospital Aintree, Liverpool, UKHana MullerovafEpidemiology, GlaxoSmithKline R&D, Stockley Park, Middlesex, UKDavid A. Lomas**Dept of Medicine, University of Cambridge, Cambridge Institute for Medical Research, Cambridge, UKEmiel Wouters##Dept of Respiratory Medicine, Maastricht University Medical Centre, Maastricht, the NetherlandsPer Bakke¶¶Institute of Medicine, University of Bergen, and Dept of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwaySteve Rennard++University of Nebraska Medical Center, Omaha, NE, USACourtney Crim#GlaxoSmithKline, Research Triangle Park, NC, USABruce E. Miller§§GlaxoSmithKline, King of Prussia, PA, USAHarvey O. CoxsonffDept of Radiology, University of British Columbia, Vancouver General Hospital, Vancouver, BC, CanadaJulie C. Yates#GlaxoSmithKline, Research Triangle Park, NC, USARuth Tal-Singer§§GlaxoSmithKline, King of Prussia, PA, USAJørgen Vestbo***Dept of Respiratory Medicine, Odense University Hospital/University of Southern Denmark, Denmark, and University of Manchester, Manchester Academic Health Sciences Centre, UK
- Clinical and prognostic heterogeneity of C and D GOLD groupsBy Alvar Agustí, Stephen Rennard, Lisa D. Edwards, William MacNee, Emiel Wouters, Bruce Miller, Ruth Tal-Singer, Hana Mullerova and Bartolomé CelliAlvar Agustí1Thorax Institute, Hospital Clinic, IDIBAPS, University of Barcelona and CIBER Enfermedades Respiratorias (CIBERES), Barcelona, SpainStephen Rennard2Dept of Pulmonary and Critical Care Medicine, University of Nebraska Medical Center, Omaha, NE, USALisa D. Edwards3Clinical Statistics, GlaxoSmithKline R&D, Research Triangle Park, NC, USAWilliam MacNee4ELEGI Labs, University of Edinburgh, Edinburgh, UKEmiel Wouters5Dept of Respiratory Medicine, Maastricht University Medical Center, Maastricht, The NetherlandsBruce Miller6Respiratory Therapy Area Unit, GlaxoSmithKline R&D, King of Prussia, PA, USARuth Tal-Singer6Respiratory Therapy Area Unit, GlaxoSmithKline R&D, King of Prussia, PA, USAHana Mullerova7Worldwide Epidemiology, GlaxoSmithKline R&D, Uxbridge, EnglandBartolomé Celli8Dept of Respiratory Medicine, Brigham and Women's Hospital, Boston, MA, USA
- Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPDBy Roberto A. Rabinovich, Bruce E. Miller, Karolina Wrobel, Kareshma Ranjit, Michelle C. Williams, Ellen Drost, Lisa D. Edwards, David A. Lomas, Stephen I. Rennard, Alvar Agustí, Ruth Tal-Singer, Jørgen Vestbo, Emiel F.M. Wouters, Michelle John, Edwin J.R. van Beek, John T Murchison, Charlotte E Bolton, William MacNee and Jeffrey T.J. HuangArticle | Published in 2016 in European Respiratory JournalRoberto A. Rabinovich1Edinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens' Medical Research Institute, Edinburgh, UKBruce E. Miller2Respiratory Therapy Area Unit, GSK, King of Prussia, PA, USAKarolina Wrobel3Medical Research Institute, School of Medicine, University of Dundee, Dundee, UKKareshma Ranjit1Edinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens' Medical Research Institute, Edinburgh, UKMichelle C. Williams4University/BHF Centre for Cardiovascular Science, Edinburgh, UKEllen Drost1Edinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens' Medical Research Institute, Edinburgh, UKLisa D. Edwards5PAREXEL International, Durham, NC, USADavid A. Lomas6Faculty of Medical Sciences, University College London, London, UKStephen I. Rennard7Division of Pulmonary, Critical Care, Sleep and Allergy, University of Nebraska, Omaha, NE, USA8Clinical Discovery Unit, AstraZeneca, Cambridge, UKAlvar Agustí9Servei de Pneumologia, Thorax Institute, Hospital Clinic, IDIBAPS, Universitat de Barcelona and CIBER Enfermedades Respiratorias (CIBERES), Barcelona, SpainRuth Tal-Singer2Respiratory Therapy Area Unit, GSK, King of Prussia, PA, USAJørgen Vestbo10Centre for Respiratory Medicine and Allergy, Manchester Academic Health Science Centre, University Hospital South Manchester NHS Foundation Trust, Manchester, UKEmiel F.M. Wouters11Dept of Respiratory Medicine, Maastricht University Medical Centre, Maastricht, The NetherlandsMichelle John12Nottingham Respiratory Research Unit, School of Medicine, University of Nottingham, Nottingham, UKEdwin J.R. van Beek13Clinical Research Imaging Centre, Queens Medical Research Institute, Edinburgh, UKJohn T Murchison14Dept of Radiology, Royal Infirmary of Edinburgh, UKCharlotte E Bolton12Nottingham Respiratory Research Unit, School of Medicine, University of Nottingham, Nottingham, UKWilliam MacNee1Edinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens' Medical Research Institute, Edinburgh, UKJeffrey T.J. Huang3Medical Research Institute, School of Medicine, University of Dundee, Dundee, UK
- Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPDBy Roberto A. Rabinovich, Bruce E. Miller, Karolina Wrobel, Kareshma Ranjit, Michelle C. Williams, Ellen Drost, Lisa D. Edwards, David A. Lomas, Stephen I. Rennard, Alvar Agustí, Ruth Tal-Singer, Jørgen Vestbo, Emiel F.M. Wouters, Michelle John, Edwin J.R. van Beek, John T Murchison, Charlotte E Bolton, William MacNee and Jeffrey T.J. HuangRoberto A. Rabinovich1Edinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens' Medical Research Institute, Edinburgh, UKBruce E. Miller2Respiratory Therapy Area Unit, GSK, King of Prussia, PA, USAKarolina Wrobel3Medical Research Institute, School of Medicine, University of Dundee, Dundee, UKKareshma Ranjit1Edinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens' Medical Research Institute, Edinburgh, UKMichelle C. Williams4University/BHF Centre for Cardiovascular Science, Edinburgh, UKEllen Drost1Edinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens' Medical Research Institute, Edinburgh, UKLisa D. Edwards5PAREXEL International, Durham, NC, USADavid A. Lomas6Faculty of Medical Sciences, University College London, London, UKStephen I. Rennard7Division of Pulmonary, Critical Care, Sleep and Allergy, University of Nebraska, Omaha, NE, USA8Clinical Discovery Unit, AstraZeneca, Cambridge, UKAlvar Agustí9Servei de Pneumologia, Thorax Institute, Hospital Clinic, IDIBAPS, Universitat de Barcelona and CIBER Enfermedades Respiratorias (CIBERES), Barcelona, SpainRuth Tal-Singer2Respiratory Therapy Area Unit, GSK, King of Prussia, PA, USAJørgen Vestbo10Centre for Respiratory Medicine and Allergy, Manchester Academic Health Science Centre, University Hospital South Manchester NHS Foundation Trust, Manchester, UKEmiel F.M. Wouters11Dept of Respiratory Medicine, Maastricht University Medical Centre, Maastricht, The NetherlandsMichelle John12Nottingham Respiratory Research Unit, School of Medicine, University of Nottingham, Nottingham, UKEdwin J.R. van Beek13Clinical Research Imaging Centre, Queens Medical Research Institute, Edinburgh, UKJohn T Murchison14Dept of Radiology, Royal Infirmary of Edinburgh, UKCharlotte E Bolton12Nottingham Respiratory Research Unit, School of Medicine, University of Nottingham, Nottingham, UKWilliam MacNee1Edinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens' Medical Research Institute, Edinburgh, UKJeffrey T.J. Huang3Medical Research Institute, School of Medicine, University of Dundee, Dundee, UK
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
